Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning.
Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales...
On Friday, the FDA issued a warning to patients and providers describing the dangers of diabetes management devices and software that haven’t been assessed by the agency. These include any unapproved or unauthorized continuous glucose monitors, insulin pumps and automated insulin dosing systems, whether used as a standalone device or integrated as part of a glucose management system.
“These...
The Centers for Medicare and Medicaid Services will reverse a longstanding unpopular position on reimbursement for smartphone-connected continuous glucose monitors, CMS announced yesterday.
"CMS heard from numerous stakeholders who shared their concerns that Medicare’s CGM coverage policy limited their use of CGMs in conjunction with their smartphones, preventing them from sharing data with...
Three former Dexcom employees left the company last year to form a new venture, Glucovation, which is developing a direct-to-consumer, wearable device that continuously senses glucose for people trying to lose weight or improve their athletic performance. The Glucovation team is headed up by Dexcom's former senior technical director for R&D, Robert Boock, who was in charge of that company's...
IMS Research seems to pile on to growing number of research reports that point to wearable devices as an important trend in digital health: According to IMS by 2016 the "minimum revenue opportunity" for wearable devices will be $6 billion.
IMS Research notes that the current market for wearable devices is concentrated around a small group of products in the healthcare, medical, fitness, and...
